Hop On A Cure Announces Grant for Duke University ALS Clinic Study on Efficacy of BL-001 in People With ALS

August 13, 2024 9:00 AM

Duke University's Dr. Richard Bedlack to Receive Hop On A Cure Inaugural Accelerate A Miracle Project Award for Research ExcellenceATLANTA, GA / ACCESSWIRE / August 13, 2024 / Hop On A Cure, a leading advocate in the fight against ALS, announced today their grant placement with Duke University's pilot trial to investigate the safety, tolerability, and preliminary efficacy of BL-001 probiotic in people with ALS. Having found a direct connection...

Read more

From Pharmacist to International Food Markets, Javid Javdani Shares His Tips for Success

August 13, 2024 8:45 AM

Javid Javdani, a distinguished Doctor of Pharmacy and successful entrepreneur based in San Diego, California recently shared his insights in an interview with Infinite Sights. The interview explores Javid's inspiring journey from a young immigrant to a leading figure in the food retail industry.Javid's story is a testament to his dedication to innovation, community service, and excellence. Born in Iran, Javid immigrated to the United States in...

Read more

Gilead and the Elton John AIDS Foundation Announce Additional Five Years of RADIAN Partnership To Help Address the Growing HIV Crisis in Eastern Europe and Central Asia

August 13, 2024 8:45 AM

Gilead Sciences, Inc. (Nasdaq:GILD) and the Elton John AIDS Foundation (EJAF) announced a five-year extension of the RADIAN ® partnership to help meet the needs of the most vulnerable key populations in Eastern Europe and Central Asia (EECA) where the HIV epidemic is growing. RADIAN will continue supporting the initiatives of trusted, grassroots organizations who are working to address HIV-related challenges in the region.While HIV is declining...

Read more

Phase 1b/2 "RAINIER" Frontline Acute Myeloid Leukemia (AML) Trial Initiated

August 13, 2024 8:05 AM

Aptevo's lead candidate APVO436 (mipletamig) to be evaluated in combination with standard of care venetoclax and azacitidineCompany anticipates new data set to bolster existing compelling data reported to date, including efficacy outcomes more than double the benchmarks*Outcomes also expected to identify recommended Phase 2 doseAPVO436 renamed as mipletamig: Aptevo adopts new generic name for future useSEATTLE, WA / ACCESSWIRE / August 13, 2024...

Read more

Compassion Center Expresses Gratitude to Rebecca Siewert of N.W. Classic and Woodburn Property Management for Highlighting Housing Disparities in Oregon

August 13, 2024 8:00 AM

Compassion Center, headquartered in Hillsboro, Oregon, is a pioneer in integrative healthcare, dedicated to improving global quality of life through individualized treatment plans that blend allopathic, traditional, and alternative modalities. Through the Center for Incubation & Findings Research (CIFR), we address socio-economic challenges like housing instability, food security, and access to mental health and integrative healthcare,...

Read more

Jaguar Health Reports Second Quarter 2024 Financial Results

August 13, 2024 8:00 AM

SAN FRANCISCO, CA / ACCESSWIRE / August 13, 2024 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today reported its consolidated second-quarter 2024 financial results and provided Company updates.The combined net revenue for the Company's crofelemer prescription products, Mytesi® and Canalevia®-CA1, and the Company's non-prescription products, was approximately $2.72 million in the second quarter of 2024, representing an increase...

Read more

Vytalize Health Named Fastest-Growing Private Company in America by Inc. Magazine

August 13, 2024 7:15 AM

Company Ranks No. 1 on the Prestigious Inc. 5000 Across All Industries After Achieving $1.5 Billion in Revenue for 2023 and a Remarkable Three-Year Revenue Growth Rate of 90,778%HOBOKEN, NJ / ACCESSWIRE / August 13, 2024 / Vytalize Health, a leading risk-bearing provider enablement platform, announced it ranked No. 1 on the 2024 Inc. 5000 list of fastest-growing private companies in America. The company achieved the top ranking with a remarkable...

Read more

Phytopathological Disease Diagnostics Market Is Expected to Reach USD 163.4 Million by 2034 And Grow at A CAGR of 4.5% | Future Market Insights, Inc.

August 13, 2024 7:00 AM

The global phytopathological disease diagnostics market is estimated to reach USD 105.2 million in 2024. Projecting forward, the market is expected to reach USD 163.4 million by 2034, reflecting a steady CAGR of 4.5% during the forecast. The industry is primarily driven by the increasing global demand for food security and sustainable agriculture practices. With rising concerns about crop diseases and their impact on yield and quality, there is...

Read more

Bausch Health Announces 2024 Gastrointestinal Health Scholars Program Winners

August 13, 2024 7:00 AM

For Fifth Consecutive Year, 10 Students with Gastrointestinal Disease Will Each Receive a $10,000 ScholarshipLAVAL, QC / ACCESSWIRE / August 13, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and its gastroenterology (GI) business, Salix Pharmaceuticals ("Salix"), today announced the recipients of its 2024 Salix Gastrointestinal Health Scholars Program. For the fifth year, Bausch Health is proud to award 10 deserving students living...

Read more

Cantargia Presents the Interim Report for Q2 2024 on August 28 at 3.00 p.m.

August 13, 2024 4:15 AM

LUND, SE / ACCESSWIRE / August 13, 2024 / Cantargia (STO:CANTA) Cantargia (Cantargia AB; Nasdaq Stockholm:CANTA) will publish the company's interim report for January to June 2024 on Wednesday, August 28, 2024, at 07:00 a.m. CEST. In conjunction to the report, Cantargia invites investors, analysts, and media to an audiocast with teleconference (in English) on August 28, at 3:00 p.m. CEST, where Cantargia's CEO, Göran Forsberg, and CFO, Patrik...

Read more

New Scientific Article on NeuroRestore ACD856 and its Improved Cognition and Disease Modification of Alzheimer’s Disease

August 13, 2024 2:20 AM

STOCKHOLM, SE / ACCESSWIRE / August 13, 2024 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical company that develops candidate drugs for diseases affecting the nervous system, focusing on Alzheimer's disease and pain, today announced that a scientific article has been published on the underlying biological mechanisms behind the NeuroRestore platform and the interesting opportunities this entails...

Read more

Evotec Announces Strong Progress in Strategic Protein Degradation Partnership with Bristol Myers Squibb

August 13, 2024 2:00 AM

Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) today announced further strong progress of the Company's strategic partnership with Bristol Myers Squibb relating to building a molecular glue-based pipeline. Performance-based and programme-based achievements trigger payments of in total US$ 75 m to Evotec.Initiated in 2018, the partnership combines Evotec's high-performance multi-omics screening and...

Read more

Dr. Greg Hanley Joins Action Behavior Centers

August 12, 2024 1:10 PM

Action Behavior Centers is thrilled to announce the appointment of Dr. Greg Hanley, BCBA-D as the Executive Director of Compassionate Care, who will be heading a new organization-wide initiative to train, mentor and support clinicians in the provision of compassionate and effective treatment for challenging behavior. Dr. Hanley brings over 25 years of experience in leadership roles, serving in both academic and clinical settings and has more...

Read more

REMINDER: Jaguar Health to Hold Investor Webcast Tuesday, August 13th at 8:30 AM Eastern to Review Q2 Earnings and Further Review Phase 3 OnTarget Trial’s Clinically Meaningful Results in Breast and Lung Cancer Patients

August 12, 2024 10:00 AM

SAN FRANCISCO, CA / ACCESSWIRE / August 12, 2024 / Jaguar Health, Inc. (NASDAQ:JAGX) today issued a reminder that the company will conduct an investor webcast on Tuesday, August 13, 2024 at 8:30 a.m. Eastern to review second-quarter 2024 financials and provide corporate updates.Participation Instructions for WebcastWhen: Tuesday, August 13, 2024 at 8:30 AM Eastern TimeParticipant Registration & Access Link: Click HereReplay Instructions for...

Read more

BioTech Medics-OTC CEO Interview and the Company Launches Its YouTube Channel

August 12, 2024 9:00 AM

WOODLAND HILLS, CA / ACCESSWIRE / August 12, 2024 / BioTech Medics, Inc. (OTC PINK:BMCS) is pleased to announce that the company's CEO sat down for an interview with The Beast of Wall Street on August 8, 2024 to discuss the past present and future of BioTech Medics, Inc. This interview can be found at the following link: https://x.com/dsalzarulo/status/1821592473652883916?s=46 additionally an excerpt of this interview can be found on the...

Read more

Monogram Technologies Secures Initial Strategic Clinical Trial Collaboration

August 12, 2024 8:30 AM

Monogram Technologies Inc. (NASDAQ:MGRM) ("Monogram" or the "Company"), an AI-driven robotics company focused on improving human health with an initial focus on orthopedic surgery, today announced its strategic collaboration with Shalby Limited (NSE:SHALBY) ("Shalby"), a global muti-specialty hospital chain and one of India's leading orthopedic hospital groups, to conduct a multicenter clinical trial to demonstrate the safety and effectiveness...

Read more

MIRA Pharmaceuticals Unveils Ketamir-2's Principal Metabolite: Nor-Ketamir - a Longer-Acting, Brain Penetrating and Selective Compound Acting on the NMDA PCP Receptor

August 12, 2024 8:00 AM

This breakthrough in bioavailability and formulation showcases the potential for advanced, at home neurological treatments.MIAMI, FL / ACCESSWIRE / August 12, 2024 / MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), or MIRA Pharmaceuticals, a leading pre-clinical-stage pharmaceutical company unveiled new preclinical data providing further insights into the mechanism of action of its innovative drug candidate, Ketamir-2's principal metabolite,...

Read more

CBD Life Sciences, Inc. (CBDL) Welcomes Major Political Endorsement for Cannabis Legalization

August 12, 2024 8:00 AM

CBD Life Sciences Inc. (OTC PINK:CBDL), including its wholly owned subsidiary, The CBD Vault Inc., a rapidly expanding CBD company headquartered in Scottsdale, Arizona, proudly supports the recent endorsement of cannabis legalization by the Harris-Walz presidential ticket. This historic move marks the first time a major U.S. presidential ticket has openly advocated for the federal legalization of cannabis, a development that could significantly...

Read more

R1 RCM Named Top Performing Revenue Cycle Management Outsourcing Provider by 2024 Black Book Health Systems Client Survey

August 12, 2024 8:00 AM

Managed services customers validated highest client satisfaction ratings on R1 RCM, a major player in the medical financial services industry that is working with 95 of the top 100 U.S. health systems and managing over $55 billion in net patient revenue.TAMPA, FL / ACCESSWIRE / August 12, 2024 / R1 RCM has been recognized as the premier vendor for outsourced Revenue Cycle Management (RCM) services tailored to health systems, networks, and...

Read more

Ainos to Participate in Fireside Chat with Water Tower Research on August 22, 2024

August 12, 2024 8:00 AM

Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos", or the "Company"), a diversified healthcare company focused on novel AI-powered point-of-care testing ("POCT") and VELDONA low-dose interferon therapeutics, today announced that it will participate in a fireside chat with Do Kim, senior research analyst of Water Tower Research ("WTR") on Thursday, August 22, 2024 at 10:00 a.m. ET.Mr. Jack Lu, Ainos' Director of Corporate Development, will provide...

Read more